Pascal Biosciences Inc Statistics
Pascal Biosciences Inc (8DZ) Stock Statistics & Valuation Metrics
Total Valuation
Pascal Biosciences Inc has a market cap or net worth of EUR 504.14K. The enterprise value is EUR 1.32M.
- Market Cap
- EUR 504.14K
- Enterprise Value
- EUR 1.32M
Share Statistics
Pascal Biosciences Inc has 39,662,727 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 39,662,727
- Owned by Insiders
- 4.76%
- Owned by Institutions
- ―
Financial Efficiency
Pascal Biosciences Inc’s return on equity (ROE) is -0.28 and return on invested capital (ROIC) is -23.94%.
- Return on Equity (ROE)
- -0.28
- Return on Assets (ROA)
- -0.16
- Return on Invested Capital (ROIC)
- -23.94%
- Return on Capital Employed (ROCE)
- -0.30
- Revenue Per Employee
- 847.83K
- Profits Per Employee
- -137.54K
- Employee Count
- 2
- Asset Turnover
- 0.99
- Inventory Turnover
- 5.81
Valuation Ratios
The current PE Ratio of Pascal Biosciences Inc is -3.05. Pascal Biosciences Inc’s PEG ratio is -0.10.
- PE Ratio
- -3.05
- PS Ratio
- 0.57
- PB Ratio
- 0.83
- Price to FCF
- 8.51
- Price to Operating Cash Flow
- 8.51
- PEG Ratio
- -0.10
Income Statement
In the last 12 months, Pascal Biosciences Inc had revenue of 1.70M and earned -275.07K in profits. Earnings per share was -0.01.
- Revenue
- 1.70M
- Gross Profit
- 396.31K
- Operating Income
- -290.45K
- Pretax Income
- -275.07K
- Net Income
- -275.07K
- EBITDA
- -32.66K
- Earnings Per Share (EPS)
- -0.01
Cash Flow
In the last 12 months, operating cash flow was 93.88K and capital expenditures 3, giving a free cash flow of 93.88K billion.
- Operating Cash Flow
- 93.88K
- Free Cash Flow
- 93.88K
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Pascal Biosciences Inc pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 11.75%
- Earnings Yield
- -38.98%
Stock Price Statistics
- Beta
- -3.68
- 52-Week Price Change
- -8.33%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.02
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Pascal Biosciences Inc upcoming earnings date is Mar 25, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 16, 2026
- Next Earnings Date
- Mar 25, 2027
- Ex-Dividend Date
- ―
Financial Position
Pascal Biosciences Inc as a current ratio of 0.75, with Debt / Equity ratio of 25.20%
- Current Ratio
- 0.75
- Quick Ratio
- 0.45
- Debt to Market Cap
- 0.12
- Net Debt to EBITDA
- -4.35
- Interest Coverage Ratio
- -5.38
Taxes
In the past 12 months, Pascal Biosciences Inc has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Pascal Biosciences Inc EV to EBITDA ratio is -9.17, with an EV/FCF ratio of 12.42.
- EV to Sales
- 0.83
- EV to EBITDA
- -9.17
- EV to Free Cash Flow
- 12.42
- EV to Operating Cash Flow
- 12.42
Balance Sheet
Pascal Biosciences Inc has EUR 60.85K in cash and marketable securities with EUR 394.63K in debt, giving a net cash position of -EUR 333.79K billion.
- Cash & Marketable Securities
- EUR 60.85K
- Total Debt
- EUR 394.63K
- Net Cash
- -EUR 333.79K
- Net Cash Per Share
- -EUR 0.01
- Tangible Book Value Per Share
- EUR 0.00
Margins
Gross margin is 29.40%, with operating margin of -23.79%, and net profit margin of -22.13%.
- Gross Margin
- 29.40%
- Operating Margin
- -23.79%
- Pretax Margin
- -22.13%
- Net Profit Margin
- -22.13%
- EBITDA Margin
- -9.04%
- EBIT Margin
- -24.03%
Analyst Forecast
The average price target for Pascal Biosciences Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 3.31%
- EPS Growth Forecast
- 31.75%

